Prepubertal children treated with inhaled glucocorticoids for asthma show an initial reduced growth velocity. [1] When these observations were first made, it was not known whether the initial drop in ...

More children stopped using steroid inhalers to control their asthma after a manufacturer discontinued a popular inhaler, a new study says. In 2024, GlaxoSmithKline withdrew Flovent from the market.

Inhalers that combine providing immediate relief with a longer-term preventative effect are already recommended as the standard treatment for mild asthma among people aged 12 and above in the UK, US ...

The market withdrawal of the brand-name asthma drug fluticasone propionate (Flovent) was linked to increased discontinuation of inhaled steroid therapy among children who had used the drug, a ...

GSK withdrew the inhaler after a policy change exposed the company to higher Medicaid rebate costs WEDNESDAY, April 30, 2025 (HealthDay News) — More children stopped using steroid inhalers to control ...

NEW YORK (Reuters Health) - Daily inhaled steroid therapy is recommended to keep mild-to-moderate asthma from flaring up, but it seems there are children whose condition remains poorly controlled even ...

Please provide your email address to receive an email when new articles are posted on . Even low-dose treatment courses of inhaled corticosteroids for asthma can lead to adrenal suppression including ...

A single combined-drug inhaler used as needed protects adults with mild asthma from worsening illness and hospital stays, a recent commentary on Cochrane systematic review data reports. But long-term ...

NEW YORK (Reuters Health) - People with milder asthma symptoms tend to fare better in the long-term if they start using inhaled steroids early on, a new study suggests. General guidelines suggest that ...